‹ All stocks

ImageneBio Inc

IMA · NASDAQ · Healthcare

$4.77

▲ $4.77 (3.47%)

1D 7D 1M 3M 1Y All

Day range

$4.55 – $4.77

Year range

$3.94 – $9.10

Open

$4.61

Previous close

—

Market cap

$53.80M

Volume (24h)

$254

Volume (52w)

$1.21K

Performance

▲ 2.80%

▼ -5.54%

▼ -21.42%

▲ 4.38%

▼ -44.60%

YTD

▼ -29.44%

▼ -90.06%

▼ -96.85%

All-time

▼ -98.76%

Key statistics

P/E ratio

-1.69

EPS (TTM)

$-2.82

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

11.3M

About ImageneBio Inc

ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1156.42	0.49%
JNJ Johnson & Johnson	$254.52	-0.58%
ABBV AbbVie	$262.04	0.29%
MRK Merck & Co.	$139.70	-2.76%
UNH UnitedHealth Group Incorp…	$371.61	-0.19%